Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Finger

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Hazardous Materials|June 24, 2026
Roofing materials as reservoirs of persistent chemical warfare agents: Fate and detectabilityTomas Rozsypal, Vladimir Finger
European Journal of Medicinal Chemistry|December 2, 2022
Pyrimidine derivatives with antitubercular activityVladimir Finger, Martin Kufa, Ondrej Soukup, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizonMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
Journal of Medicinal Chemistry|October 7, 2025
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case StudiesOndrej Kovar, Martin Kufa, Vladimir Finger, et al.
Archives of Toxicology|August 23, 2023
A-agents, misleadingly known as "Novichoks": a narrative reviewJakub Opravil, Jaroslav Pejchal, Vladimir Finger, et al.
Biomolecules|December 30, 2020
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and <i>N</i>-Methyl-d-Aspartate Receptor AntagonistsJan Konecny, Anna Misiachna, Martina Hrabinova, et al.
Bioorganic Chemistry|April 30, 2026
Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibitionAbdullah Al Mamun, Jan Konecny, Martina Hrabinova, et al.
European Journal of Medicinal Chemistry|December 24, 2025
Novel pyrimidine derivatives as promising antimycobacterial agentsMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluationFilip Pidany, Jana Kroustkova, Abdullah Al Mamun, et al.
International Journal of Molecular Sciences|June 10, 2023
Structure-Guided Design of <i>N</i>-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's DiseaseBarbora Svobodova, Lenka Pulkrabkova, Dawid Panek, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Hazardous Materials|June 24, 2026
Roofing materials as reservoirs of persistent chemical warfare agents: Fate and detectabilityTomas Rozsypal, Vladimir Finger
European Journal of Medicinal Chemistry|December 2, 2022
Pyrimidine derivatives with antitubercular activityVladimir Finger, Martin Kufa, Ondrej Soukup, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizonMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
Journal of Medicinal Chemistry|October 7, 2025
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case StudiesOndrej Kovar, Martin Kufa, Vladimir Finger, et al.
Archives of Toxicology|August 23, 2023
A-agents, misleadingly known as "Novichoks": a narrative reviewJakub Opravil, Jaroslav Pejchal, Vladimir Finger, et al.
Biomolecules|December 30, 2020
Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and <i>N</i>-Methyl-d-Aspartate Receptor AntagonistsJan Konecny, Anna Misiachna, Martina Hrabinova, et al.
Bioorganic Chemistry|April 30, 2026
Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibitionAbdullah Al Mamun, Jan Konecny, Martina Hrabinova, et al.
European Journal of Medicinal Chemistry|December 24, 2025
Novel pyrimidine derivatives as promising antimycobacterial agentsMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluationFilip Pidany, Jana Kroustkova, Abdullah Al Mamun, et al.
International Journal of Molecular Sciences|June 10, 2023
Structure-Guided Design of <i>N</i>-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's DiseaseBarbora Svobodova, Lenka Pulkrabkova, Dawid Panek, et al.
Pageof 2